Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­ researchers have joined forces with GARDP to develop new antibiotics
12 April 2019

In an Australian-first, Â鶹´«Ã½Ó³»­ of Queensland will join forces with the (GARDP) to tackle the growing problem of drug-resistant infections.

GARDP, a not-for-profit research and development group initiated by the World Health Organization, develops new or improved antibiotic treatments.

Dr Mark Blaskovich from Â鶹´«Ã½Ó³»­’s (CO-ADD) said about 700,000 people died of drug-resistant infections every year.

“CO-ADD at Â鶹´«Ã½Ó³»­’s Institute for Molecular Bioscience has helped the global chemistry community identify more than 1500 potential new antibiotics since its launch in 2015,” he said.

“We are looking forward to applying our screening expertise to discover new antibiotics within the interesting libraries of chemical compounds identified by GARDP.

“International initiatives such as this are essential to refuel the antibiotic pipeline, which has been neglected in recent years, placing us dangerously close to a return to the pre-antibiotic era, when even simple infections caused death.”

Â鶹´«Ã½Ó³»­ Vice-Chancellor and President Professor Peter Høj AC said the partnership was an opportunity for Â鶹´«Ã½Ó³»­ to help create meaningful change in the fight against antibiotic resistance.

“We have chosen to invest in addressing the critical need for research and development of new antibiotics, not just for our benefit but also for future generations who deserve the same access to life-saving treatments that we currently enjoy,” he said.

CO-ADD will have access to libraries of chemical compounds from the US translational research institute and natural products from Germany’s .

GARDP’s Professor Laura JV Piddock said the aim of the partnership was to discover new compounds or drug combinations and to ensure new antibiotics were available to everyone who needed them.

“We’re very excited about the announcement as natural products have yielded many of the antibiotics developed for clinical use to date,” she said.

The partnership announcement coincides with the experts will present their latest findings.

Media: IMB Communications, communications@imb.uq.edu.au, +61 (0) 405 661 856; Dr Mark Blaskovich, m.blaskovich@imb.uq.edu.au, +61 (0) 414 955 380.